- Staat
- NJ
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 08.09.2023
- Impfdatum
- 14.06.2023
- Beginn
- 18.06.2023
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dermatitis acneiform
Rash
Rash pruritic
Symptomtext
rash on right leg/patient described the rash as itchy; Patient described the rash as itchy and looked like little pimples; This spontaneous report was received from a physician and refers to a 27 year old female patient. The patient's concurrent conditions included allergy to ciprofloxacin (CIPRO). Her medical history and concomitant medications were not reported. On 14-JUN-2023, the patient was vaccinated with the fist dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # U029496, expiration date not provided but upon internal review stablished as 21-SEP-2023) administered intramuscular (IM) in the left upper arm as routine vaccination. On 18-JUN-2023 (also reported as 3 - 4 days after receiving vaccine), the patient experienced several lesions of rash on her right leg which were itchy and looked like little pimples (rash pruritic, dermatitis acneiform). No treatment was given for these events, and on 02-JUL-2023, the patient recovered from the events (also reported as lasted for about 2 weeks). On 21-AUG-2023, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # W089697, expiration date not provided but upon internal review stablished as 13-DEC-2024) administered in the left upper arm (route of administration not provided) as routine vaccination. Causality assessment between the events and varicella virus vaccine live (oka/merck)(VARIVAX) was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergic reaction to antibiotics; Routine immunisation
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 23.01.2023
- Impfdatum
- 23.01.2023
- Beginn
- 01.01.2023
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Injection site erythema
Symptomtext
redness in skin around injection site and red patches on upper back and chest lasting <30 min, faded, no shortness of breath, itching or other allergic symptoms. Benadryl liquid administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 17.01.2023
- Impfdatum
- 10.01.2023
- Beginn
- 11.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blister rupture
C-reactive protein increased
Cellulitis
Eosinophil count increased
Eosinophil percentage increased
Full blood count abnormal
Influenza virus test negative
Injection site erythema
Injection site oedema
Injection site pain
Injection site pruritus
Injection site vesicles
Injection site warmth
Lymphocyte percentage
Mean cell haemoglobin concentration decreased
Monocyte count increased
Neutrophil count
Purulent discharge
Symptomtext
pt received kinrix and varicella immunizations on 1/10/2023. mom and patient noticed erythema and edema to L lateral upper arm 1/11/2023 in the morning... . which then increased significantly by 1/12/2023 [date of follow up visit at our office].. also c/o warm to touch, pruritis, and pain with pressure to area. pt reports multiple blisters that ruptured (drained yellow pus). erythema surrounding location of kinrix administration. Pt sent to hospital ER for further workup and evaluation. diagnosed with cellulitis. given one dose of abx and sent home with keflex (8ml TID x 7days).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- labs from 1/12/2023: CRP elevated 18.7 CBC (WBC elevated 10.4, RBC elevated 5.18, MCHC elevated 26, lymphocytes elevated 24.3, eosinophils elevated 6.2, ANC elevated 6.38, monocyte abs ct elevated 0.80, eosino abs count elevated 0.64 covid negative flu negative rsv negative
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- laryngotracheomalacia
- Andere Medikamente
- none
- Allergien
- dairy, soy, pineapple
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.11.2023
- Impfdatum
- -
- Beginn
- 06.11.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
No additional AEs or PQC reported.; Caller reported expired dose of VARIVAX administered. No other information provided. No additional AEs or PQC reported.; This spontaneous report was received from a physician and refers to a patient of unspecified age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) injection, (lot number U029496 has been confirmed to be valid for varicella virus vaccine live (oka/merck) (VARIVAX)) expiration date reported as 21-SEP-2023) the expired vaccine was administered to the patient (Expired product administered) (strength, route of administration, and indication were not provided). At the time of reporting, the outcome of the event was not unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- F
- Eingang
- 15.12.2022
- Impfdatum
- 10.11.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
temperature excursion and reported VARIVAX that had undergone temperature excursion was administered to a patient; No additional AE reported; This spontaneous report was received from medical assistant and refers to an approximately 18-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 10-NOV-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) valid lot #U029496, expiration date: 21-SEP-2023, administered for prophylaxis (strength, and route of administration were not provided). That vaccine experienced a temperature excursion (Product storage error). It was reported that there was a previous temperature excursion, which was -10 degrees Celsius (C) up to 8 C (-7.2C) for 7 hours 54 minutes and 0 seconds, and the current excursion was -10 C up to 8 C (0.1C) for 444 hours 0 minutes and 0 seconds (also reported as 442). No further information was provided. No additional adverse event was reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 02.12.2022
- Impfdatum
- 10.11.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported.; MMR II and VARIVAX that had undergone temperature excursion was administered to a patient; This spontaneous report was received from a Certified Medical Assistant concerning a 17-year-old male patient. Their concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 10-NOV-2022, the patient was vaccinated with an improperly storage dose varicella virus vaccine live (Oka/Merck) (VARIVAX) administered as prophylaxis, lot number U029496 with expiration date 21-SEP-2023 (dosage regimen and route of administration were not reported), and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live recombinant human albumin (rHA) (M-M-R II) administered as prophylaxis, lot number U013036 with expiration date 23-APR-2023 (dosage regimen and route of administration were not reported). The vaccines underwent a temperature excursion of -10 C up to 8 C (0.1 C) for 444 hours minutes and 0 seconds, with a previous temperature excursion of -10 C up to 8 C (-7.2 C) for 7 hours 54 minutes and 0 seconds (Product storage error). No additional adverse events were reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.09.2022
- Impfdatum
- 30.08.2022
- Beginn
- 30.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE; Caller reported that VARIVAX and PROQUAD that underwent a temperature excursion were administered; This spontaneous report has been received from a health care worker concerning to patient of unknown age and gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, a temperature excursion occurred for varicella virus vaccine live (oka/merck) (VARIVAX) in which the maximum temperature was from 6 to 14 degrees Fahrenheit for a timeframe of 50 minutes. No previous temperature excursions were reported. On 30-AUG-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U029496, expiration date 21-SEP-2023 (dose, route of administration and anatomical location were not provided) for prophylaxis (product storage error). No additional events were reported. This is one of three reports from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 02.08.2022
- Impfdatum
- 02.08.2022
- Beginn
- 02.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Incorrect product formulation administered
Symptomtext
Vaccines were drawn up and needles attached to pre drawn syringes by myself and another nurse for 2 clients coming in for immigration vaccines. I pulled Private vaccines for this clients, as this cilent had , while her partner had vaccines, which I pulled for him also. I accidently pulled out the pediatric dose of the Hep. B and upon adminstering it, I realized by the volume amount that it was, a pediatric dose was given and not an adult dose. So an Adult dose of Hep. B was given to the client after realizing the error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.07.2022
- Impfdatum
- 14.06.2022
- Beginn
- 14.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; a dose of VARIVAX that experienced a temperautre excursion was administered to the patient after the excursion occured.; This spontaneous report was received from a medical assistant and referred to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 14-JUN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (0.5 milliliter, lot #U029496, expiration date: 21-SEP-2023) administered for prophylaxis (strength, and route of administration were not provided) (product storage error). It was reported that the suspect vaccine was exposed to a temperature of 7.7 Fahrenheit (F) for a time frame of 30 minutes. There was previous temperature excursion. No additional adverse event was reported. This is one of the several report received from the same reporter.; Sender's Comments: US-009507513-2206USA007839: US-009507513-2206USA007845:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 15.07.2022
- Impfdatum
- 05.07.2022
- Beginn
- 05.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental overdose
No adverse event
Symptomtext
No additional AE reported.; Nurse reports that a twelve month old patient was accidently administered both VARIVAX and PROQUAD on Jul 5, 2022.; This spontaneous report has been received from a registered nurse concerning a 12-month-old patient of unknown gender. The concomitant medications, medical history, drug reactions or allergies, and concurrent conditions were not reported. On 05-JUL-2022, the patient was accidently administered both measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) once, lot # W002785, expiration date 24-JUL-2023 (strength, dose, route of administration and anatomical location were not provided) and varicella virus vaccine live (oka/merck) (VARIVAX) once, lot # U029496, expiration date 21-SEP-2023 (strength, dose, route of administration and anatomical location were not provided) for prophylaxis (accidental overdose). No further information was provided. No additional adverse event (AE) was reported. No product quality complaints (PQC) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.07.2022
- Impfdatum
- 24.05.2022
- Beginn
- 24.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; dose of VARIVAX that experienced a temperautre excursion was administered to the patient after the excursion occured; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 24-MAY-2022,, improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter lot #U029496 expiration date: 21-SEP-2023 (route of administration and anatomical location were not provided) was administered for prophylaxis. The vaccine experienced a temperature excursion of 7.3 degree Fahrenheit four 2 hours (product storage error). There was previous temperature excursion. No additional adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA007855: US-009507513-2206USA007845: US-009507513-2206USA007717: US-009507513-2206USA007710: US-009507513-2206USA007839: US-009507513-2206USA007547: US-009507513-2206USA007894: US-009507513-2206USA007527: US-009507513-2206USA007706: US-009507513-2206USA007910: US-009507513-2206USA007693:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 08.07.2022
- Impfdatum
- 05.07.2022
- Beginn
- 05.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
Patient received incorrect vaccine. No current reportable side effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 07.07.2022
- Impfdatum
- 06.06.2022
- Beginn
- 06.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental overdose
No adverse event
Wrong product administered
Symptomtext
No additional AE/PQC.; PROQUAD and VARIVAX was administered to a patient concomitantly instead of MMR II and VARIVAX; Accidental overdose; This spontaneous report was received from a medical assistant and refers to a 12-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 06-JUN-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, rHA, 0.5 ml/once, lot # W006587, expiration date: 23-AUG-2023, administered for prophylaxis (strength and route of administration were not provided) and varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml/once, lot #U029496, expiration date: 21-SEP-2023, administered for prophylaxis (strength, and route of administration were not provided) concomitantly instead of measles, mumps, and rubella (WISTAR RA 27-3) virus vaccine, live (MMR II) and varicella virus vaccine live (oka/merck) (VARIVAX) (wrong product administered and accidental overdose). No side effects reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; temperature excursion VARIVAX has been administered; This spontaneous report was received from a medical assistant referring to a 4-year-old female patient. The patient's illness at vaccination and pre-existing allergies, birth defects and medical conditions were reported as none. The birth weight was 7 lbs and 9.3 oz. The patient had 1 sister and 1 brother. Concomitant therapy included sterile diluent (manufacturer unknown), diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (KINRIX) and measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live (M-M-R II). On 01-JUN-2022, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number U029496, expiration date: 21-SEP-2023) (The vaccine underwent a temperature excursion of 5.5 Celsius degree for 5 hours and 6 minutes on 26-MAY-2022 (vaccine was moved to refrigerator to deforest freezer at 07:49, returned to freezer at 12:55, min temperature in fridge: 4.46 Celsius degree, max temperature in fridge: 5.55 Celsius degree, the excursion occurred as a result of digital data logger)) 0.5 ml subcutaneously at left thigh for prophylaxis (product storage error) at a private doctor's office. No adverse event was reported (no adverse event). The vaccine was used according to the instruction leaflet. The vaccine was in freezer and available for return/evaluation. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA007524:MSD US-009507513-2206USA007508:MSD US-009507513-2206USA007509:MSD US-009507513-2206USA007510:MSD US-009507513-2206USA007511:MSD US-009507513-2206USA007512:MSD US-009507513-2206USA001254:MSD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT; KINRIX; M-M-R II
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; temperature excursion VARIVAX has been administered; This spontaneous report was received from a medical assistant referring to a 4-year-old male patient. The patient's illness at vaccination and pre-existing allergies, birth defects and medical conditions were reported as none. The birth weight was 7 lbs 10 oz. The patient had no siblings. Concomitant therapy included sterile diluent (manufacturer unknown), diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (KINRIX) and measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live (M-M-R II). On 01-JUN-2022, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number U029496, expiration date: 21-SEP-2023) (The vaccine underwent a temperature excursion of 5.5 Celsius degree for 5 hours and 6 minutes on 26-MAY-2022 (vaccine was moved to refrigerator to deforest freezer at 07:49, returned to freezer at 12:55, min temperature in fridge: 4.46 Celsius degree, max temperature in fridge: 5.55 Celsius degree, the excursion occurred as a result of digital data logger)) 0.5 ml subcutaneously at right thigh for prophylaxis (product storage error) at a private doctor's office. No adverse event was reported (no adverse event). The vaccine was used according to the instruction leaflet. The vaccine was in freezer and available for return/evaluation. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA007524: US-009507513-2206USA007508: US-009507513-2206USA007509: US-009507513-2206USA007510: US-009507513-2206USA007512: US-009507513-2206USA007513: US-009507513-2206USA001254:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; temperature excursion VARIVAX has been administered; This spontaneous report was received from a medical assistant referring to a 2-year-old (also reported as 22 months) female patient. The patient's illness at vaccination were reported as none. The pre-existing allergies, birth defects and medical conditions included optic nerve hypoplasia. The birth weight was 8 lbs and 3 oz. The patient had one brother. Concomitant therapy included sterile diluent (manufacturer unknown), hepatitis a vaccine inact (HAVRIX), hib vaccine conj (tet tox) (HIBERIX) and diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) tetanus vaccine toxoid (INFANRIX). On 01-JUN-2022, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number U029496, expiration date: 21-SEP-2023) (The vaccine underwent a temperature excursion of 5.5 Celsius degree for 5 hours and 6 minutes on 26-MAY-2022 (vaccine was moved to refrigerator to deforest freezer at 07:49, returned to freezer at 12:55, min temperature in fridge: 4.46 Celsius degree, max temperature in fridge: 5.55 Celsius degree, the excursion occurred as a result of digital data logger)) 0.5 ml subcutaneously at left thigh for prophylaxis at a private doctor's office (Product storage error). No adverse event was reported (no adverse event). The vaccine was purchased with public funds. The vaccine was used according to the instruction leaflet. The vaccine was in freezer and available for return/evaluation. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001254: US-009507513-2206USA007524: US-009507513-2206USA007508: US-009507513-2206USA007510: US-009507513-2206USA007511: US-009507513-2206USA007512: US-009507513-2206USA007513:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Optic nerve hypoplasia
- Andere Medikamente
- STERILE DILUENT; HAVRIX; HIBERIX; INFANRIX
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 04.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; temperature excursion VARIVAX has been administered; This spontaneous report was received from a medical assistant referring to a 4-year-old female patient. The patient's illness at vaccination was otitis media. The pre-existing allergies, birth defects and medical conditions were reported as none. The birth weight was 9 lbs and 2.5 oz. The patient had 2 sisters. Concomitant therapies included sterile diluent (manufacturer unknown), diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (KINRIX) and measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live (M-M-R II). On 01-JUN-2022, the patient was vaccinated with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number U029496, expiration date: 21-SEP-2023) (The vaccine underwent a temperature excursion of 5.5 Celsius degree for 5 hours and 6 minutes on 26-MAY-2022 (vaccine was moved to refrigerator to deforest freezer at 07:49, returned to freezer at 12:55, min temperature in fridge: 4.46 Celsius degree, max temperature in fridge: 5.55 Celsius degree, the excursion did not occur as a result of digital data logger)) (Product storage error) 0.5 ml subcutaneously at right thigh for prophylaxis (product storage error) at a private doctor's office. No adverse event was reported (no adverse event).The vaccine was purchased with public funds. The vaccine was used according to the instruction leaflet. The vaccine was in freezer and available for return/evaluation. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001254: US-009507513-2206USA007509: US-009507513-2206USA007510: US-009507513-2206USA007511: US-009507513-2206USA007512: US-009507513-2206USA007513: US-009507513-2206USA007524:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Otitis media
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT; KINRIX; M-M-R II
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 04.07.2022
- Impfdatum
- 31.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; temperature excursion VARIVAX has been administered; This spontaneous report was received from a medical assistant referring to a 15-month-old female patient. The patient's illness at vaccination and pre-existing allergies, birth defects and medical conditions were reported as none. The birth weight was 7 lbs and 11.8 oz. The patient had one sister and one brother. Concomitant therapies included sterile diluent (manufacturer unknown) and HIB vaccine conj (tet tox) (HIBERIX). On 31-MAY-2022, the patient was vaccinated with the second dose of temperature excursion varicella virus vaccine live (oka/merck) (VARIVAX) (lot number U029496, expiration date: 21-SEP-2023) 0.5 ml subcutaneously at left thigh for prophylaxis (product storage error) at a private doctor's office. No adverse event was reported (no adverse event). The vaccine was purchased with public funds. The vaccine was used according to the instruction leaflet. The vaccine was in freezer and available for return/evaluation. The vaccine underwent a temperature excursion of 5.5 Celsius degree for 5 hours and 6 minutes (vaccine was moved to refrigerator to deforest freezer at 07:49, returned to freezer at 12:55, min temperature in fridge: 4.46 Celsius degree, max temperature in fridge: 5.55 Celsius degree, the excursion occurred as a result of digital data logger). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA007524: US-009507513-2206USA007508: US-009507513-2206USA007509: US-009507513-2206USA007510: US-009507513-2206USA007511: US-009507513-2206USA007512: US-009507513-2206USA007513:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 25.05.2022
- Beginn
- 25.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; Medical assistant reporting that a patient was administered VARIVAX after a temperature excursion.; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, previous drug reactions, or allergies were not provided. On 25-MAY-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number U029496 has been verified to be a valid lot number, expiry date 21-SEP-2023) (strength, dose, frequency, route of administration, anatomical location and vaccination scheme were not provided). The vaccine was stored at a temperature of 8.3 Fahrenheit (F) for the time frame of 0 hours 15 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse events reported. This is one of several reports received from the same reporter. As of 07-JUN-2022, no further information is available.; Sender's Comments: US-009507513-2206USA000990: US-009507513-2206USA000886:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 14.06.2022
- Beginn
- 14.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse event (No additional AE reported); VARIVAX that experienced a temperautre excursion was administered to the patient after the excursion occured; This spontaneous report has been received from a medical assistant, regarding a patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drugs reactions or allergies and concomitant medications were not reported. On 14-JUN-2022, the patient was vaccinated with an improperly storage dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection 0,5 milliliters (ml) as prophylaxis (lot number: U029496, which was determined to be valid, with an expiration date on 21-SEP-2023) (scheme, route and anatomical location of administration were not reported) (product storage error). Administered dose underwent a temperature excursion of 7.7 degrees Fahrenheit (F) for 30 minutes. It was reported that there was a previous temperature excursion. No additional adverse event was reported. This is one of several cases reported by the same reporter.; Sender's Comments: US-009507513-2206USA007839: US-009507513-2206USA007845:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Immunisation
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; Caller reports that a dose of VARIVAX that experienced a temperautre excursion was administered to the patient after the excursion occured.; This spontaneous report has been received from a medical assistant, regarding a patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drugs reactions or allergies and concomitant medications were not reported. On 01-JUN-2022, the patient was vaccinated with an improperly storage dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection 0,5 milliliters (ml) as prophylaxis (lot number: U029496, which was determined to be valid, with an expiration date on 21-SEP-2022) (scheme, route and anatomical location of administration were not reported) (product storage error). Administered dose underwent a temperature excursion of 7.7 degrees Fahrenheit (F) for 30 minutes. It was reported that there was a previous temperature excursion. No additional adverse event was reported. This is one of several cases reported by the same reporter.; Sender's Comments: US-009507513-2206USA007693: US-009507513-2206USA007710: US-009507513-2206USA007717: US-009507513-2206USA007675: US-009507513-2206USA007839: US-009507513-2206USA007845: US-009507513-2206USA007547: US-009507513-2206USA007894: US-009507513-2206USA007527: US-009507513-2206USA007706: US-009507513-2206USA007910:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE reported.; Caller reports that a dose of VARIVAX that experienced a temperautre excursion was administered to the patient after the excursion occured.; This spontaneous report has been received from a medical assitant, concerning to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided. On 01-JUN-2022, the patient was administered vaccine varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliters (ml), subcutaneous injection (valid lot number U029496 [expiration date 21-SEP-2023]) for prophylaxis, after a temperature excursion of 7.7 degrees Fahrenheits (F) for 30 minutes (product storage error) (vaccination scheme, and frequency were not provided). Additionally, a previous temperature excursion was reported. No additional adverse events (AE) were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA007717: US-009507513-2206USA007710: US-009507513-2206USA007693: US-009507513-2206USA007675: US-009507513-2206USA007547: US-009507513-2206USA007910: US-009507513-2206USA007894: US-009507513-2206USA007855: US-009507513-2206USA007845: US-009507513-2206USA007706: US-009507513-2206USA007527:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- -
- Beginn
- 18.06.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE reported; dose of VARIVAX that experienced a temperautre excursion was administered to the patient after the excursion occured; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml, lot # U029496, expiration date: 21-SEP-2023, administered for prophylaxis (strength, dose number and route of administration were not provided) (product storage error). Administered dose of vaccine experienced the temperature excursion of 7.7 degrees Fahrenheit for 30 minutes.; Sender's Comments: US-009507513-2206USA007839:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 23.06.2022
- Beginn
- 23.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; administered to the patient after the excursion occured; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 23-JUN-2022, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot #U029496, expiration date: 21-SEP-2023, administered (strength and route of administration were not provided) for prophylaxis (Product storage error). On an unknown date, before the administration, the vaccine underwent temperature excursion at 7.7 Fahrenheit degrees (F) for 30 minutes. No previous temperature excursions were reported. No adverse events were reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 16.06.2022
- Impfdatum
- -
- Beginn
- 25.04.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No adverse event; TE evaluation states vaccines have been administered; This spontaneous report was received from a medical assistant regarding a 5-year-old male patient. There was no information about the patient's drug reactions or allergies, medical history, concurrent conditions, nor concomitant medications. On 23-MAR-2022, a temperature excursion occurred. On 25-APR-2022, the patient was vaccinated with second dose at private doctor's office/hospital; vaccine as purchased by public funds by a health care professional (1 previous administrated dose) of varicella virus vaccine live (oka/merck) (VARIVAX) administrated subcutaneously (SQ) (formulation, strength, dose, vaccination scheme, and anatomical site of vaccination were not reported, lot numbers U025790 or U029496, which had been verified to be valid, expiration dates reported and validated as 19-AUG-2023 and 21-SEP-2023 respectively), as prophylaxis (Improper storage of product in use). The vaccine administered was stored at temperatures that went, from -14 degrees Celsius (C) up to -10 C for a time frame of 3 hours, and from -10 C up to 8 C for 1 hours 30 minutes, as recorded by a data logger. There was no previous temperature excursion. No additional AE details were reported. No PQC. Additionally, the vaccine was not available for evaluation because it was given to the patient; usage for device was initial use. This is one of multiple reports received from the same reporter.; Sender's Comments: US-009507513-2205USA008004: US-009507513-2205USA008051: US-009507513-2205USA007852: US-009507513-2205USA007821:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.06.2022
- Impfdatum
- 31.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Medical assistant reporting that a patient was administered VARIVAX after a temperature excursion. No additional information provided. Additional AE cases: 02177149, 02177161, 02177162, 02177163, 02177164, 02177165, 02177166, 02177167, 02177168 filed; This spontaneous report was received from a medical assitant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 31-MAY-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot number U029496, expiration date 21-SEP-2023 for prophylaxis (dose and route of administration not reported) (product storage error). The vaccine underwent a temperature excursion of 8.3 degrees Farhrenheit for 15 minutes. No previous excursions were detected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.06.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
A patient was administered VARIVAX after a temperature excursion; This spontaneous report was received from a medical assitant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 01-JUN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot number U029496, expiration date 21-SEP-2023 for prophylaxis (dose and route of administration not reported) (product storage error). The vaccine underwent a temperature excursion of 8.3 degrees Farhrenheit for 15 minutes. No previous excursions were detected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 1,9
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 01.06.2022
- Beginn
- 02.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
Pt received extra dose of Varicella, MMR, and PCV13
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- NONE
- Andere Medikamente
- UKNOWN
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 13.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- 11.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Parents were notified by physician
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- -
- Geschlecht
- U
- Eingang
- 19.04.2022
- Impfdatum
- 23.03.2022
- Beginn
- 23.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
Symptomtext
Administration of MMR and VARIVAX intramuscularly; This spontaneous report was received from a physician's assistant concerning a patient of unspecified age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-MAR-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot # U029496, expiration date: 21-SEP-2023, administered intramuscularly (unapproved route) as prophylaxis (strength, was not provided); and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #U006486, expiration date: 26-FEB-2023, administered intramuscularly (unapproved route) as prophylaxis (strength was not provided).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- -
- Geschlecht
- M
- Eingang
- 11.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Male patient recruits at the Clinic, were given expired Pfizer vaccine with the lot number FF2587. The original expiration date was DEC 2021 and was extended 90 days to MAR 2022. The Pfizer was 4 days past the expiration date when given. No adverse signs and symptoms noted, appropriated providers notified. Patients are currently being monitored for any other reactions. Pfizer has data to support stability of the lot number FF2587 through JUNE 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NA
- Vorherige Impfungen
- -
